Private Wealth Management Group’s United Therapeutics UTHR Stock Holding History

Private Wealth Management Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.6K	Hold	27	–	–	﹤0.01%	470
2026 Q1	$16K	Hold	27	–	–	﹤0.01%	385
2025 Q4	$13.2K	Hold	27	–	–	﹤0.01%	430
2025 Q3	$11.3K	Hold	27	–	–	﹤0.01%	473
2025 Q2	$7.76K	Sell	27 -2	-7%	-$598	﹤0.01%	576
2025 Q1	$8.94K	Hold	29	–	–	﹤0.01%	505
2024 Q4	$10.2K	Hold	29	–	–	﹤0.01%	462
2024 Q3	$10.4K	Hold	29	–	–	﹤0.01%	446
2024 Q2	$9.24K	Buy	29 +18	+164%	+$4.76K	﹤0.01%	460
2024 Q1	$2.53K	Sell	11 -3	-21%	-$677	﹤0.01%	872
2023 Q4	$3.08K	Buy	+14	New	+$3.23K	﹤0.01%	794

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Private Wealth Management Group's UTHR Position: Q2 2026 in Review

Private Wealth Management Group held its United Therapeutics (UTHR) position steady in Q2 2026 at 27 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

Private Wealth Management Group first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $16K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Private Wealth Management Group held 27 shares of United Therapeutics worth $14.6K as of Q2 2026.
Private Wealth Management Group left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #470 holding.
Private Wealth Management Group first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
Private Wealth Management Group's United Therapeutics position peaked at $16K in Q1 2026.
875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.